NFA
INO icon

Nationwide Fund Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Nationwide Fund Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,698
Closed -$281K – 1006
2017
Q3 		$281K Buy
3,698
+474
+15% +$35.3K ﹤0.01% 2469
2017
Q2 		$303K Hold
3,224
– – ﹤0.01% 2441
2017
Q1 		$256K Sell
3,224
-255
-7% -$20.3K ﹤0.01% 2477
2016
Q4 		$290K Sell
3,479
-160
-4% -$14.5K ﹤0.01% 2448
2016
Q3 		$407K Hold
3,639
– – ﹤0.01% 2274
2016
Q2 		$404K Sell
3,639
-176
-5% -$21.4K ﹤0.01% 2256
2016
Q1 		$413K Sell
3,815
-129
-3% -$9.96K ﹤0.01% 2186
2015
Q4 		$318K Buy
3,944
+68
+2% +$5.41K ﹤0.01% 2322
2015
Q3 		$269K Hold
3,876
– – ﹤0.01% 2420
2015
Q2 		$380K Buy
3,876
+231
+6% +$24.7K ﹤0.01% 2402
2015
Q1 		$357K Sell
3,645
-155
-4% -$15K ﹤0.01% 2415
2014
Q4 		$419K Sell
3,800
-65
-2% -$7.94K ﹤0.01% 2287
2014
Q3 		$457K Buy
3,865
+3
+0.1% +$374 ﹤0.01% 2269
2014
Q2 		$501K Buy
+3,862
New +$456K ﹤0.01% 2261

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nationwide Fund Advisors's INO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Inovio Pharmaceuticals (INO) in Q4 2017, closing a stake of 3,698 shares — an estimated $281K sold.

Nationwide Fund Advisors first reported a position in INO in Q2 2014 and held it in 14 quarters. The position peaked at $501K in Q2 2014. 133 funds tracked by Wall St. Rank hold INO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Inovio Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 3,698 Inovio Pharmaceuticals shares in Q4 2017, an estimated $281K.
  • Nationwide Fund Advisors first reported a position in Inovio Pharmaceuticals in Q2 2014 and held it in 14 quarters.
  • Nationwide Fund Advisors's Inovio Pharmaceuticals position peaked at $501K in Q2 2014.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.